RESUMEN
Pathogenic invasion by Escherichia coli and Salmonellae remains a constant threat to the integrity of the intestinal epithelium and can rapidly induce inflammatory responses. At birth, colostrum consumption exerts numerous beneficial effects on the properties of intestinal epithelial cells and protects the gastrointestinal tract of newborns from pathogenic invasion. The present study aimed to investigate the effect of colostrum on the early and late inflammatory responses induced by pathogens. The short-term (2 h) and long-term (24 h) effects of exposure to heat-killed (HK) E. coli and Salmonella enterica Typhimurium on gene expression in the porcine intestinal epithelial cell (IPEC-J2) model were first evaluated by microarray and quantitative PCR analyses. Luciferase assays were performed using a NF-κB-luc reporter construct to investigate the effect of colostrum whey treatment on the activation of NF-κB induced by HK bacteria. Luciferase assays were also performed using NF-κB-luc, IL-8-luc and IL-6-luc reporter constructs in human colon adenocarcinoma Caco-2/15 cells exposed to dose-response stimulations with HK bacteria and colostrum whey. Bovine colostrum whey treatment decreased the expression of early and late inflammatory genes induced by HK bacteria in IPEC-J2, as well as the transcriptional activation of NF-κB-luc induced by HK bacteria. Unlike that with colostrum whey, treatment with other milk fractions failed to decrease the activation of NF-κB-luc induced by HK bacteria. Lastly, the reduction of the HK bacteria-induced activation of NF-κB-luc, IL-8-luc and IL-6-luc by colostrum whey was dose dependent. The results of the present study indicate that bovine colostrum may protect and preserve the integrity of the intestinal mucosal barrier in the host by controlling the expression levels of early and late inflammatory genes following invasion by enteric pathogens.
Asunto(s)
Calostro/metabolismo , Enterocitos/metabolismo , Escherichia coli/inmunología , Regulación de la Expresión Génica , FN-kappa B/antagonistas & inhibidores , Salmonella typhimurium/inmunología , Suero Lácteo/metabolismo , Animales , Células CACO-2 , Bovinos , Línea Celular , Enterocitos/inmunología , Enterocitos/microbiología , Genes Reporteros , Humanos , Inmunidad Mucosa , Interleucina-6/antagonistas & inhibidores , Interleucina-6/genética , Interleucina-6/metabolismo , Interleucina-8/antagonistas & inhibidores , Interleucina-8/genética , Interleucina-8/metabolismo , Cinética , FN-kappa B/genética , FN-kappa B/metabolismo , Regiones Promotoras Genéticas , Proteínas Recombinantes de Fusión/química , Proteínas Recombinantes de Fusión/metabolismo , Sus scrofaRESUMEN
BACKGROUND AND AIMS: Sphingolipids (SL) are important components of the milk fat globule membrane (MFGM) found in buttermilk. While studies in animal models suggest that dietary SL may have cholesterol-lowering properties, data in human are lacking. The aim of this study was to investigate the impact of buttermilk consumption on plasma lipids and surrogate markers of cholesterol (C) homeostasis in humans. METHODS AND RESULTS: Men and women (n = 34) with serum LDL-C <5.0 mmol/L at screening (mean LDL-C = 3.8 mmol/L) were recruited in this double-blinded randomized crossover placebo controlled study. Their diets were supplemented with 45 g/d of buttermilk and with 45 g/d of a macro/micronutrient matched placebo (4 weeks each in random order). Serum lipid concentrations and surrogate markers of cholesterol homeostasis were measured post diet and compared using mixed models for repeated measures. Consumption of buttermilk led to reduction in serum cholesterol (-3.1%, P = 0.019), LDL-C (-3.1%, P = 0.057) and triacylglycerol (-10.7%, P = 0.007). Buttermilk consumption increased plasma lathosterol concentrations (+12.1%, P = 0.001), but multiple regression analysis indicated that variations in ß-sitosterol concentrations (P = 0.002) were the only significant predictor of the LDL-C response to buttermilk consumption. CONCLUSION: Buttermilk consumption may be associated with reduced cholesterol concentrations in men and women, primarily through inhibition of intestinal absorption of cholesterol. REGISTRATION NUMBER: This trial is registered at clinicaltrials.gov as NCT01248026.
Asunto(s)
Biomarcadores/sangre , LDL-Colesterol/sangre , Productos Lácteos Cultivados , Homeostasis/fisiología , Adolescente , Adulto , Anciano , Colesterol/sangre , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Absorción Intestinal/fisiología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Análisis de Regresión , Medición de Riesgo , Factores de Riesgo , Adulto JovenRESUMEN
BACKGROUND: XP-828L is a nutraceutical compound obtained by the extraction of a growth factors-enriched protein fraction from bovine milk. XP-828L may improve psoriasis. OBJECTIVES: An open-label study was performed to determine the efficacy, tolerability and safety of XP-828L in the treatment of plaque psoriasis. METHODS: Eleven adult patients with chronic, stable plaque psoriasis on 2% or more of body surface area (BSA) received 5 g of oral XP-828L twice daily for 56 days. RESULTS: All 11 patients completed the 56 days of treatment. At day 28, 6 of the 11 patients showed a reduction in PASI score. At 56 days, seven subjects had a decrease in PASI score ranging from 9.5% to 81.3%. Eight (8) out of 11 patients agreed to participate in an additional 8-week extension treatment phase. Improvement of psoriasis was maintained during the extension period. No clinically significant adverse events or laboratory abnormalities occurred. CONCLUSION: XP-828L may improve psoriasis in patients with mild-to-moderate psoriasis.
Asunto(s)
Proteínas de la Leche/uso terapéutico , Psoriasis/terapia , Administración Oral , Adulto , Anciano , Femenino , Estudios de Seguimiento , Humanos , Inmunoglobulinas , Consentimiento Informado , Lactalbúmina , Lactoferrina , Masculino , Persona de Mediana Edad , Proteínas de la Leche/administración & dosificación , Psoriasis/diagnóstico , Factores de Tiempo , Resultado del TratamientoRESUMEN
Yogurts were prepared by using yogurt cultures combined to mixed cultures of bifidobacteria (Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, and Bifidobacterium longum) and by adding a preincubation step (1.5 h at 50 degrees C) with bifidobacteria to the conventional method of manufacture in order to produce oligosaccharides. The survival of bifidobacteria was drastically affected during storage of yogurts, except for products containing B. animalis, in which viable counts remained at >10(6) cfu/g after 28 d of storage at 4 degrees C. Oligosaccharides with a degree of polymerization of 3 were produced during the preincubation step (0.31 to 0.68%), and the amount in the final products varied according to the species of bifidobacteria inoculated during the preincubation step or the concentration of bifidobacteria used as second inoculum during the fermentation process. In fact, the higher concentration of oligosaccharides measured at the end of the fermentation process (0.72%) and the 28 d-storage period (0.67%) was obtained for yogurts containing B. infantis. However, yogurts containing B. breve showed higher beta-galactosidase activities and had lower lactose concentrations after the fermentation process and the storage period than the other yogurts. The use of a mixed cultures of bifidobacteria (B. animalis, B. infantis, or B. breve) thus allows the production of yogurts in which bifidobacteria can survive in relatively high cell numbers and contain appreciable amount of oligosaccharides.
Asunto(s)
Bifidobacterium/metabolismo , Oligosacáridos/biosíntesis , Yogur/microbiología , Bifidobacterium/crecimiento & desarrollo , Recuento de Colonia Microbiana , Fermentación , Conservación de Alimentos , Concentración de Iones de Hidrógeno , Lactobacillus/aislamiento & purificación , Lactosa/análisis , Especificidad de la Especie , Streptococcus/aislamiento & purificación , Temperatura , Factores de Tiempo , Yogur/análisis , beta-Galactosidasa/metabolismoRESUMEN
The purpose of this study was to evaluate the shelf-life stability (6 months) of model infant formula with whey protein hydrolysates or peptidic fractions as carrageenan replacers. Whey protein hydrolysates were prepared with trypsin and followed by ultrafiltration of the hydrolyzed mixture, and peptidic fractions were isolated from the ultrafiltered tryptic hydrolysate by anion- or cation-exchange chromatography. The stability of the model infant formula was evaluated using a stratification method based on fat content differences between the top and bottom strata of the samples. With protein hydrolysate-based formulations, the creaming rate of the fat in the product was slightly higher than in the standard formulation (with carrageenan), which is indicative of lower storage stability. The addition of cationic fractions to model infant formula also resulted in lower product stability, whereas the fat creaming rate was retarded in anionic fraction based formulations. The physicochemical characteristics of certain peptides combined with the reported high emulsifying properties of peptidic sequences found within these fractions may account for their ability to act as carrageenan replacers.
Asunto(s)
Conservación de Alimentos/normas , Alimentos Infantiles/normas , Proteínas de la Leche/metabolismo , Animales , Fraccionamiento Químico , Cromatografía Líquida de Alta Presión , Cromatografía por Intercambio Iónico , Emulsiones , Humanos , Lactante , Alimentos Infantiles/análisis , Recién Nacido , Proteínas de la Leche/análisis , Peso Molecular , Hidrolisados de Proteína/metabolismo , Tripsina/metabolismo , Proteína de Suero de LecheRESUMEN
An in vitro digestion method to assess the quality of proteins based on enzymatic hydrolysis is presented. The method consists of a two-step proteolysis at 37 degrees, a 30-minute incubation of the protein with pepsin at pH 1.9, followed by pancreatin digestion at pH 8 for 24 hours in a dialysis bag with a 1000 molecular weight cutoff for the continuous elimination of the digested products into a replaceable buffer. Three types of buffer replacement were tried. These were, in increasing order of efficiency: intermittent with either six changes (infrequent buffer replacement) or eleven changes (frequent buffer replacement) or continuously circulated at the rate of 212 ml/hour (continuous buffer replacement). By using three protein sources, i.e., casein, soybean and rapeseed proteins, it was found that the degree of digestion (dialyzed N) as well as the regularity of the process were markedly improved by increasing the frequency of buffer replacement. In spite of different pepsin digestibilities, as determined from the production of trichloroacetic acid-soluble N, the digestion of the three proteins gave equivalent results when the best procedure of buffer replacement was used (continuous buffer replacement). The deleterious effect of heat and alkali treatment on protein digestion was readily shown by this procedure and indicated casein to be a very heat-sensitive protein as compared to the others.